Crohn Disease
- Subcutaneous Infliximab Therapy Efficacious for Inflammatory Bowel Disease
- Methotrexate for Pediatric CD Viable Primary Maintenance Therapy
- IBD Medication in Men Not Linked to Adverse Pregnancy Outcomes
- Ustekinumab Drug Monitoring Predictive of Disease Activity in CD
- Ustekinumab, Vedolizumab May Effectively Prevent Postoperative Recurrence in CD
- Dual-Energy CT Enterography a Viable Alternative to Endoscopy for CD
- Cesarean Delivery Linked to Increased Risk for Crohn Disease in Children
- Global Trends in Rates of IBD Hospitalization Examined
- Diagnostic Accuracy of MRE Indices Studied for Active CD
- Rheumatoid Arthritis Likely Plays Causal Role in Inflammatory Bowel Disease
- No Improved Outcomes With Therapeutic Drug Monitoring in IBD Treatment
- Psychosocial Burden Common Among Patients With Inflammatory Bowel Disease
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
